Kohl’s Cuts Corporate Staff Again to Reduce Costs
Back in February, Kohl’s (NYSE: KSS) announced that it was laying off 250 corporate employees in an effort to streamline its management, speed up …
Next Stock Market Crash Prediction
Next Stock Market Crash Prediction: Spring 2020 brought an unprecedented stock market crash that quickly rebounded to new highs. Some believe it’s only a …
After Years of Setbacks, Apple Launches Online Sales in India This Week
Apple (NASDAQ: AAPL) has been trying to expand its presence in India over the past decade, but faced numerous setbacks related to local regulations. Back in …
A Social Security Test Only 1 in 300 Seniors Could Ace
Recently, Americans between the ages of 60 and 70 were asked five crucial questions about Social Security. Only one in 300 answered them all correctly, …
Southwest Airlines’ Cash Burn Improves Again
Building and preserving a cash stockpile has been the name of the game for airlines ever since the COVID-19 pandemic caused air travel demand to crater earlier …
This ETF Could Help Grow Your Retirement Account
Did you know there are roughly 7,000 exchange-traded funds (ETFs) available globally? If you’re looking to add an ETF to your retirement account, you …
Now We Know Who at Berkshire Invested in Snowflake, and Why
The hottest IPO of the year is cloud-based data warehouse provider Snowflake (NYSE: SNOW). It was initially slated to go public at $75 to $85 per share last …
3 Things to Watch For Before You Buy Aurora Cannabis Stock
Aurora Cannabis (NYSE: ACB), once a favorite among pot investors because of its bold expansion strategy, lost steam in 2019. Aurora’s shares declined 56% …
3 Things IBM Wants You to Know About Its Cloud Strategy
International Business Machines (NYSE: IBM) has long been a prominent name in the technology industry. However, the tech stock has suffered in recent years as …
What Can Investors Learn From the Explosion of IPOs?
In August, a number of popular tech companies announced plans for their initial public offerings (IPO). This is exciting for many investors who are looking for …
4 Must-Have Documents for a Peaceful Retirement
Most people can’t wait for retirement, and even more would likely opt for some form of early retirement if they had the opportunity. Whenever you …
3 Top Biotech Picks for 2025
When it comes to astronomical returns in investing, one of the most important factors — aside from buying the right company — is buying your shares …
Market Crash 2.0: 2 Stocks to Buy Right Now to Keep Your Portfolio Safe
The last time there was a market crash, it was COVID-19-related concerns that sent investors into a panic. While the markets have recovered since then, amidst …
These 3 Stocks Could Soar if Biden Beats Trump
The U.S. election on Nov. 3 could bring a change to the highest office in the land and create new opportunities for some promising companies. We asked three …
Here’s Why Municipal Bonds Belong in Every Investor’s Portfolio
You’ll often hear that to grow serious wealth, you can’t tie up the bulk of your money in bonds. The reason? Though stocks are more volatile than …
3 Software Stocks Share This 1 Key to Success
Would you buy a car without driving it first? I’m sure it happens, but I can’t imagine anyone who would do so by choice. Buying software is no …
3 Compelling Biotech Stocks to Consider Buying While They’re Hot on Robinhood
Traders on the Robinhood investing app are notorious for picking highly speculative stocks — and as a group, they’re too powerful to ignore if …
3 Companies Tesla Should Be Worried About in 2021
Tesla’s (NASDAQ: TSLA) market cap has surged to over $400 billion in 2020 as investors have bought into everything from Tesla’s growth to its …
New Retirees Better Prepare for 25% Smaller Social Security Checks at 73
Social Security has long been one of the most important sources of income that retirees receive. But while these benefits should provide a reliable, steady …
Does Cassava Sciences Have the Alzheimer’s Disease Drug We’ve Been Waiting For?
Shares of Cassava Sciences (NASDAQ: SAVA) rocketed higher last week in response to compelling results from a clinical trial with sumifilam, an experimental …